Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

Venous thromboembolism (VTE) is common in patients with cancer and is an important contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated only in those cancer patients at highest risk for VTE would be optimal. Risk stratification scores incorporating tumor locat...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiva, Orly, Connors, Jean M., Al-Samkari, Hanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409200/
https://www.ncbi.nlm.nih.gov/pubmed/32707653
http://dx.doi.org/10.3390/cancers12071958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409200/
https://www.ncbi.nlm.nih.gov/pubmed/32707653
http://dx.doi.org/10.3390/cancers12071958

Ejemplares similares